Lyme Disease Cognitive Impairment: Persistent Effects After Stroke
Lyme disease cognitive impairment can persist even after treatment and recovery from acute complications. A growing body of research suggests that infectious agents may contribute to long-term cognitive decline. :contentReference[oaicite:0]{index=0}
A study by Nimgaonkar and colleagues found that exposure to infectious agents—including CMV, HSV-1, HSV-2, and Toxoplasma gondii—was associated with cognitive deterioration in older adults, independent of age-related factors. [1]
Cognitive Impairment in Lyme Disease
Clinicians have long recognized cognitive issues following Lyme disease. Logigian described a mild encephalopathy developing months to years after infection, characterized by memory loss, mood changes, and sleep disturbances. [2]
Two-thirds of patients improved after intravenous ceftriaxone, but recovery was often incomplete. Later studies found improved outcomes with longer treatment, though persistent symptoms remained common. [3]
Fallon and colleagues reported objective memory impairment years after onset, even after antibiotic treatment. Short-term improvement was observed, but relapse often followed discontinuation of therapy. [4]
Stroke as a Presentation of Lyme Disease
A case report described a 43-year-old man who developed a stroke due to Borrelia burgdorferi infection.
The patient had no cardiovascular risk factors but presented with malaise, headache, and cognitive impairment. MRI revealed a right thalamic infarct, and cerebrospinal fluid analysis confirmed Lyme neuroborreliosis.
Persistent Cognitive Deficits Despite Treatment
After three weeks of intravenous ceftriaxone, the patient’s neurologic deficits—including hemiparesis—resolved.
However, cognitive impairment persisted.
“Despite the quick radiological and clinical response, mild short-term memory loss remained at follow-up,” the authors reported. [5]
Implications for Treatment and Recovery
This case highlights a critical issue: structural recovery does not always translate into cognitive recovery.
Current treatment guidelines may not fully address long-term cognitive outcomes, particularly when therapy is limited in duration.
Lyme disease cognitive impairment may persist despite appropriate antibiotic treatment, underscoring the need for individualized care and further research.
More studies are needed to determine optimal treatment strategies to prevent chronic cognitive complications.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
